About Joseph Avellone
Joseph Avellone is a director at Apnimed.
Joseph Avellone first appears on SEC filings in 2018.
Experience
This experience comes from Joseph Avellone's profile and from SEC filings. For roles taken from filings, the years are when the filings name Joseph Avellone in the role, so the role may have started earlier or lasted longer.
MI
MMS CLINICAL RESEARCH SERVICES (MMS HOLDINGS INC.) Current
Member Board of Directors
2022 – Present
BI
Biorasi Current
Member, Board of Directors
2022 – Present
CI
Clinical Ink Current
Member, Board Of Directors
2021 – Present
CE
Celerion Current
Member, Board Of Directors
2018 – Present
Apnimed, Inc.
Member, Board Of Directors
2017 – 2026 · Cambridge, MA
Develops oral medicines for people with sleep apnea and other sleep-related breathing diseases.
CI
Cytel, Inc.
Vice Chairman, Board of Directors
2018 – 2021
PI
PAREXEL International
Executive Vice President
2007 – 2016
VM
Veritas Medicine
Chief Executive Officer
2000 – 2007
BM
Blue Cross Blue Shield of Massachusetts
Chief Operating Officer
1991 – 1997
PH
Peter Bent Brigham Hospital
General Surgery Resident
1974 – 1979
Key Colleagues at Startups
The people Joseph Avellone works with at each company, as listed on that company's latest Form D.
Apnimed, Inc. · Form D, Mar 27, 2026
LM
Lawrence Miller
Executive officer and director
Paul Fonteyne
Director
DM
Dennis Molnar
Executive officer
Barry Wohl
Chief Business Officer
FB
Francois Beaubien
Director
Chris Dimitropoulos
Director
KL
Kevin Lind
Chief Executive Officer and director
IC
Isaac Cheng
Director
GS
Gary Sender
Director
RB
Ramzi Benamar
Chief Financial Officer